classified as unclear (Hopkins et al., 2009). The uncertainty of effects was based on 90% confidence limits for all variables. A custom spreadsheet was used to perform all of the calculations (.). Results There were differences between BCAA and placebo groups for the total energy intake trivial (2486 ± 412 kcal/day 2667 ± 449 kcal/day; carbohydrate (1157 ± 354 cf. trivial, unlikely), kcal/day 1230 ± 300 kcal/day; fat (980 ± 283 kcal/day 1049 ± 275 cf. trivial, unlikely), cf. kcal/day; and protein energy intake (378 ± 79 kcal/day 394 ± 101 trivial, unlikely) cf. kcal/day; trivial, unlikely). Changes in isometric strength (% baseline) are presented in Figure 1 (mean ± SD). There were reductions in isometric strength between baseline and post-exercise for the BCAA large group (1031 ± 273 N 976 ± 238 N, respectively whilst the placebo group cf. most likely ↓), showed changes (899 ± 248 N 734 ± 186 N, respectively; By very large cf. most likely ↓). post-testing, the reduction in strength remained for the placebo group (most very large and for the BCAA group (most which were subsequently reduced to likely large likely ↓) ↓), changes among the placebo and BCAA conditions at 48-h. Both groups moderate, unclear did not return to baseline strength levels during the study. Pairwise between-group tests revealed a greater reduction in isometric strength at 24-h in the placebo group compared to the BCAA group (moderate, indicating a delayed recovery of muscle function. likely ↓), *******Figure 1 near here*******
classified as unclear (Hopkins et al., 2009). The uncertainty of effects was based on 90% confidence limits for all variables. A custom spreadsheet was used to perform all of the calculations (.). Results There were trivial differences between BCAA and placebo groups for the total energy intake (2486 ± 412 kcal/day cf. 2667 ± 449 kcal/day; trivial, unlikely), carbohydrate (1157 ± 354 kcal/day cf. 1230 ± 300 kcal/day; trivial, unlikely), fat (980 ± 283 kcal/day cf. 1049 ± 275 kcal/day; trivial, unlikely) and protein energy intake (378 ± 79 kcal/day cf. 394 ± 101 kcal/day; trivial, unlikely). Changes in isometric strength (% baseline) are presented in Figure 1 (mean ± SD). There were large reductions in isometric strength between baseline and post-exercise for the BCAA group (1031 ± 273 N cf. 976 ± 238 N, respectively most likely ↓), whilst the placebo group showed very large changes (899 ± 248 N cf. 734 ± 186 N, respectively; most likely ↓). By post-testing, the reduction in strength remained very large for the placebo group (most likely ↓) and large for the BCAA group (most likely ↓), which were subsequently reduced to moderate, unclear changes among the placebo and BCAA conditions at 48-h. Both groups did not return to baseline strength levels during the study. Pairwise between-group tests revealed a greater reduction in isometric strength at 24-h in the placebo group compared to the BCAA group (moderate, likely ↓), indicating a delayed recovery of muscle function. *******Figure 1 near here*******
Attached%20standard%20file%253a%20Main_ms_final%20copy_The_effect_of_acute_branched_chanin_amino_acid_supplementation_on_recovery_from_hypertrophy_training.docx